This year, the Swiss Venture Capital Update for the first six months includes an analysis of valuations in the financing rounds - on page 9 in the PDF (https://lnkd.in/drAndFd). Valuations for seed and early stage investments remain at a high level, but have fallen sharply in the later stage. The analysis shows that many later stage rounds are bridge financing.
Startupticker.ch
Internet-Publishing
The independent Swiss innovation news channel. Principal: Innosuisse
Info
Startupticker.ch (http://www.startupticker.ch) is the leading Swiss news portal for start-ups, supporters, innovators and investors. We are providing daily information on company results, launch of innovations, growth, financing, exits, support services, events and award tenders. The most important news and events of the week from the start-up community are sent out in a weekly newsletter. Innosuisse is the principal of startupticker.ch We are always looking for hot news and for partners interested in a cooperation.
- Website
-
http://www.startupticker.ch
Externer Link zu Startupticker.ch
- Branche
- Internet-Publishing
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Lucerne
- Art
- Nonprofit
- Gegründet
- 2011
- Spezialgebiete
- Start-ups, Venture Capital, Financing, Start-up Awards, CTI Start-up, Start-up Support und Innovation
Orte
-
Primär
Editorial Board
Hirschmattstrasse 33
Lucerne, 6003, CH
Beschäftigte von Startupticker.ch
Updates
-
Bern-based startup legal-i is this year’s Microsoft Switzerland Startup of the Year. The insurtech startup built a medical case intelligence SaaS solution allowing for up to 80% increased efficiency and 40% accuracy, as reported by several of its customers. The Microsoft Switzerland startup of the Year Award was held yesterday at the Microsoft Switzerland Parter event. Decentriq, provider of data clean rooms took home the Partner Innovation award in the cagetory ISV Innovation. Achim Kohli Markus Baumgartner legal-i Decentriq Maruscha Heyner Microsoft for Startups #insurtech #legaltech https://lnkd.in/eGsV5xRs
-
Gamaya based in Vaud and Terraview from Winterthur have merged, combining their AI-powered platforms to enhance sustainability and climate resiliency in global food production. This strategic move aims to address decarbonization and water efficiency in sugarcane and grape crops, with plans to expand into additional value chains and new markets. The merged company will operate under the GAMAYA brand. Key investors, including Seed4Equity, Glasshouse (Peter Brabeck-Letmathe Family office), ICOS Capital, the Mahindra Group, VI Partners, and Binny Bansal's 3SV (Three State Ventures), back this merger, recognizing its potential for significant global impact across the agriculture industry. #agritech #merger GAMAYA Yury Vasilkov TerraviewOS Piyush Harsh https://lnkd.in/eEeUzUDA
Two Swiss Agritechs fuse their businesses together
startupticker.ch
-
The update of the Venture Capital Report for the first half of 2024 has once again generated a strong press response. Several dozen publications were published. Moreover, Thomas Heimann, MSc was interviewed by SRF https://lnkd.in/eKPG98XC. Special thanks go to the journalists who attended our press conference and wrote the following reports: https://lnkd.in/eie7wD9x Allnews.ch, La finance suisse dans l'e-media https://lnkd.in/eA2RkUVY HANDELSZEITUNG https://lnkd.in/e7vqgJwB https://lnkd.in/eutBF8f3 AGEFI, Nouvelle Agence Économique et Financière https://lnkd.in/ehYeXsjR Le Temps SECA - Swiss Private Equity & Corporate Finance Association
SRF Börse vom 16.07.2024 - Play SRF
srf.ch
-
Following successful first clinical trials, Biopôle-based Vanarix has raised CHF 4 million from new private investors. This funding will finance the upcoming clinical trial and support the implementation of automated manufacturing processes for Cartibeads, making this treatment accessible to a larger patient population. Vannary Tieng, PhD, MBA Alessandra de Picciotto Vanarix Biopôle Lausanne https://lnkd.in/gRYqmgTv
CHF 4M and new clinical trials for Vanarix
startupticker.ch
-
Led by Novo Holdings, the latest investment in Asceneuron will be used to progress lead asset ASN51, an oral small molecule OGA inhibitor, into Phase 2 clinical development for the treatment of Alzheimer's disease. OGA is an enzyme implicated in protein aggregation. By preventing the aggregation of tau proteins, ASN51 aims to slow the progression of Alzheimer's disease. Asceneuron has completed five Phase 1 clinical trials, demonstrating complete central nervous system uptake and high OGA enzyme occupancy. Asceneuron plans to initiate its first Phase 2 clinical study later this year. Naveed Siddiqi Novo Holdings Barbara A. Asceneuron SA #Alzheimers https://lnkd.in/ebQEtqaP
Asceneuron closes $100 million series C financing round
startupticker.ch
-
In the first six months of the current year, Swiss start-ups generated a total of CHF 1,082.4 million in venture capital. This represents a decline of 9.5% on 2023. The number of financing rounds also decreased, falling by 10.4% to 138. But although the figures are roughly similar to those of last year, analysis of investment by sector and maturity level of the start-ups shows clear differences and a contradictory picture emerges. Although young start-ups from some sectors or fields such as AI and energy generation and storage are able to attract investors, late stage investment is in short supply. This half-year update to Swiss Venture Capital Report, published by the online news portal startupticker.ch and the investor association SECA in cooperation with startup.ch, shows that investors are more confident than a year ago. According to the broad-based survey of about 100 Swiss start-up investors, conducted by SECA, the vast majority expect the number of investment opportunities and the number of investments to increase. Thomas Heimann, MSc Maurice R.H. Pedergnana Andrea Villiger SECA - Swiss Private Equity & Corporate Finance Association Ulrich Geilinger Roger Wüthrich-Hasenböhler Sandra Tobler Roland Siegwart Adrienne Corboud Fumagalli Lorenzo Ambrosini Tomas Brenner Cornelia Gut-Villa Simone Riedel Riley, CFA Christian Elias Schneider #VentureCapital #Report #SVCR https://lnkd.in/ebvHx3ih
CHF 1.1 billion for Swiss start-ups: investments on consolidation course
startupticker.ch
-
Swiss Edge AI startup csky.ai has just closed its seed round, exceeding CHF 1 million of total funding inclusive of equity, grants, and loans raised since the company launch. Among the investors are several Swiss, French and American business angels, the Founderful Fund and two companies. The raised funds are set to take the startup led by Hugo Flayac closer to market entry. Hugo Flayac csky.ai Founderful unlimitrust #documentation #privacy https://lnkd.in/ewprJdDz
Csky.ai Seed funding paves way for market entry
startupticker.ch
-
Swisspod, a Swiss-American startup pioneering the hyperloop technology, has successfully closed its pre-Series A funding round, advancing plans to construct the world's largest hyperloop testing facility in the US. The capital raised will drive the development and deployment of a revolutionary high-speed transportation system set to redefine the future of passenger and freight mobility. Denis Tudor Madalina Stoicescu Swisspod Technologies #hyperloop Electrogrup https://lnkd.in/e2A6RvEj
Swisspod to build World's Largest Hyperloop Testing Hub
startupticker.ch
-
Auf dem Marktplatz von maison.work können kommerzielle Immobilienanbieter, KMU oder kleinere Bürogemeinschaften ihre Büro- und Gewerbeflächen zur Miete anbieten. Jetzt hat das 2019 gegründete Startup in einer Finanzierungsrunde bei Business Angels einen sechsstelligen Betrag eingesammelt. Die zusätzlichen Mittel werden in den technologischen Fortschritt, in Marketinginitiativen und den Ausbau des Teams investiert, um mit hohem Tempo weiter zu skalieren. 👨💻 Remo S. Dominic Frei Marc Schwery maison.work #proptech https://lnkd.in/dasTd9Fx
Frisches Geld und starkes Wachstum für maison.work
startupticker.ch